Development of an Amyloidosis Risk Score for Positive Tenosynovial Biopsy at Carpal Tunnel Release
A routine biopsy strategy maximizes sensitivity for the early detection of amyloidosis with a 15% positive biopsy rate. We furthermore present a risk score for a selective biopsy strategies with associated sensitivities and specificities.
Authors
- Robert F. Padera (ORCID: https://orcid.org/0000-0002-4571-5494)
- Dafang Zhang (ORCID: https://orcid.org/0000-0003-0155-8244)
- Jeffrey N. Katz (ORCID: https://orcid.org/0000-0003-2104-4670)
- Kyra A. Benavent (ORCID: https://orcid.org/0000-0001-5277-8277)
- Sarah Cuddy (ORCID: https://orcid.org/0000-0002-2124-2151)
- Brandon E. Earp (ORCID: https://orcid.org/0000-0002-7983-3325)
- Yuchiao Chang (ORCID: https://orcid.org/0000-0003-1093-3755)
- Richard N. Mitchell (ORCID: https://orcid.org/0000-0002-0329-7618)
- Philip Blazar (ORCID: https://orcid.org/0000-0002-2156-0053)
- Rodney H. Falk (ORCID: https://orcid.org/0000-0002-3329-2033)
- George S.M. Dyer (ORCID: https://orcid.org/0000-0002-6542-4467)
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- The Journal Of Hand Surgery
- Published
- 2025-03-07
- DOI
- https://doi.org/10.1016/j.jhsa.2025.01.028
- Citations
- 3
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.42
Funders
- AstraZeneca